SecBot SecBot
Insider Cluster (3 insiders) ·Filed Aug 24, 2026

GH

Guardant Health, Inc.
NEUTRAL
Impact 2/10
Horizonimmediate Processed2mo ago
Insider cluster: 2 insiders, $1.5M total
Actionable Insight • Neutral

Insider selling is trivial relative to market cap and does not warrant a bearish read. The Co-CEO's $1.52M sale is likely liquidity-driven given the small proportion of his stake. Monitor for any larger cluster or C-suite selling above 0.1% of market cap before adjusting view.

DirectionNeutral
Confidencehigh
Horizonimmediate

How the stock moved after the report

NEUTRAL VIEWSTOCK ABOVE ENTRY AT T+20
Entry
$164.92
T+0 close · Aug 24, 2026 · via day close
Latest settled
+6.91%
T+20 · $176.31 · next T+60 tomorrow
Vs SPY
+6.66%
α at T+20
Latest observation
+6.85%
T+57 · FF3 residual α
  1. T+0 · Aug 25 $164.92entry
  2. T+1 · 3mo ago +3.64%α +3.62% · $170.92
  3. T+5 · 3mo ago −0.31%α +0.23% · $164.41
  4. T+20 · 8w ago +6.91%α +6.66% · $176.31
  5. T+58 · todayOpen
  6. T+60 · tomorrow Pending
Loading chart...

How similar events traded

How similar events traded

See how far stocks moved after events like this one.

Subscribe for Full Access

Executive Summary

Guardant Health (GH) insiders sold $1.54M in shares over the past week, led by Co-CEO AmirAli Talasaz who sold $1.52M in a single open-market transaction on August 21. Director Roberto Mignone exercised non-cash derivative positions with no economic value. The selling represents approximately 0.007% of GH's $22.9B market cap, a trivial amount that does not signal material bearish conviction.

Key Financial Metrics

Direction
selling
Total Value
$1.5M
Insiders
3

Key Facts

  • Co-CEO AmirAli Talasaz sold 9,023 shares at $168.20 for $1.52M on 2026-08-21
  • Director Tariq Musa sold 116 shares at $156.45 for $18K on 2026-08-17
  • Director Roberto Mignone exercised non-cash derivative options (264 shares at $0) on 2026-08-21
  • Total cluster value of $1.54M is only 0.007% of GH's $22.9B market cap
  • No open-market buying activity in the cluster

Financial Impact

$1.54M in total insider sales, representing 0.007% of market cap

insider ownership

Risk Factors

  • Co-CEO selling could be perceived negatively by retail investors despite trivial size
  • No insider buying to signal confidence at current $168 price level

Market Snapshot

Exchange
Nasdaq
Sector
Services-Medical Laboratories
Analyst Consensus
91% bullish (35 analysts)

Investment Themes

Healthcare & Medical Devices

Documents Analyzed

This report is based on 1 SEC document filed with EDGAR.

DocumentAccession Number
CLUSTER Data (Synthetic)cluster-GH-1787645320556

US Market Status

Market Closed · Opens Wed (9h 43m)

Subscribe to SecBot

Get Real-Time SEC Filing Intelligence

Comprehensive SEC filing analysis delivered the moment filings hit EDGAR. Sentiment scoring, impact analysis, and actionable insights for every material event.

Create a free account Live analysis, Telegram alerts, watchlists and the MCP server for subscribers
Report published Aug 25, 2026